These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30203534)

  • 1. A pilot study comparing the efficacy of two formulations of botulinum toxin type A for muscular calves contouring.
    Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Sathaworawong A; Vanadurongwan B; Lektrakul N
    J Cosmet Dermatol; 2018 Dec; 17(6):984-990. PubMed ID: 30203534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of two formulations of botulinum toxin type A for masseter reduction: a split-face comparison study.
    Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Sathaworawong A; Lektrakul N; Manuskiatti W
    J Dermatolog Treat; 2017 Aug; 28(5):443-446. PubMed ID: 27884065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RimabotulinumtoxinB versus OnabotulinumtoxinA in the treatment of masseter hypertrophy: a 24-week double-blind randomized split-face study.
    Lee DH; Jin SP; Cho S; Feneran A; Youn CS; Won CH; Park GH; Kim BW; An J; Chang SE; Lee MW
    Dermatology; 2013; 226(3):227-32. PubMed ID: 23774030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin A treatment for contouring of the lower leg.
    Han KH; Joo YH; Moon SE; Kim KH
    J Dermatolog Treat; 2006; 17(4):250-4. PubMed ID: 16971324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A treatment for contouring of the lower face.
    Park MY; Ahn KY; Jung DS
    Dermatol Surg; 2003 May; 29(5):477-83; discussion 483. PubMed ID: 12752514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin a for aesthetic contouring of enlarged medial gastrocnemius muscle.
    Lee HJ; Lee DW; Park YH; Cha MK; Kim HS; Ha SJ
    Dermatol Surg; 2004 Jun; 30(6):867-71; discussion 871. PubMed ID: 15171764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of a Novel Botulinum Toxin A for Masseter Reduction: A Randomized, Double-Blind, Placebo-Controlled, Optimal Dose-Finding Study.
    Hong JY; Jeong GJ; Kwon TR; Kim JH; Li K; Kim BJ
    Dermatol Surg; 2021 Jan; 47(1):e5-e9. PubMed ID: 33347002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Toxin Injections for Leg Contouring in East Asians.
    Cheng J; Chung HJ; Friedland M; Hsu SH
    Dermatol Surg; 2020 Oct; 46 Suppl 1():S62-S70. PubMed ID: 31977500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, open-label comparative study of prabotulinumtoxinA with two different dosages and diverse proportional injection styles for the reduction of gastrocnemius muscle hypertrophy in Asian women.
    Suh Y; Jeong GJ; Noh H; Sun S; Hwang CH; Oh TS; Kim BJ
    Dermatol Ther; 2019 Sep; 32(5):e13009. PubMed ID: 31251444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of botulinum toxin type A on contouring of the lower face.
    Choe SW; Cho WI; Lee CK; Seo SJ
    Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Gastrocnemius Muscle Hypertrophy with Botulinum Toxin Injection Followed by Magnetic Resonance Imaging Assessment and 3-Dimensional Evaluation.
    Bogari M; Tan A; Xin Y; Chai G; Lin L; Min P; Zhang Y; Zhang Y
    Aesthet Surg J; 2017 Oct; 37(10):1146-1156. PubMed ID: 29040400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Calf Subcutaneous Fat Thickness on Patient Satisfaction after Calf Contouring with Botulinum Toxin A.
    Xu X; Liu D; Wu M; Luo L; Feng J; Ou Y; Kang Y; Panayi AC; Long Y; Cui Y
    Plast Reconstr Surg; 2024 Jul; 154(1):63e-69e. PubMed ID: 37220391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
    Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
    Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Botulinum Toxin in Treating Asian Indian Patients with Masseter Hypertrophy: A 4-Year Follow-Up Study.
    Shome D; Khare S; Kapoor R
    Plast Reconstr Surg; 2019 Sep; 144(3):390e-396e. PubMed ID: 31461011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional CT might be a potential evaluation modality in correction of asymmetrical masseter muscle hypertrophy by botulinum toxin injection.
    No YA; Ahn BH; Kim BJ; Kim MN; Hong CK
    J Cosmet Laser Ther; 2016; 18(2):113-5. PubMed ID: 26073120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and safety of a new botulinum toxin type A preparation in mouse gastrocnemius muscle.
    Na J; Lee E; Kim YJ; Choi MJ; Kim SY; Nam JS; Yun BJ; Kim BJ
    Toxicon; 2020 Nov; 187():163-170. PubMed ID: 32918927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pilot Study on the Treatment of Posterior Cheek Enlargement in HIV+ Patients With Botulinum Toxin A.
    Scali C; Carruthers A; Malpas D; Humphrey S
    Dermatol Surg; 2015 Nov; 41(11):1300-8. PubMed ID: 26469200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of gastrocnemius muscle hypertrophy for personalized botulinum toxin type A treatment.
    Liu D; Xu X; Wu M; Luo L; Feng J; Ou Y; Panayi AC; Long Y; Cui Y
    J Cosmet Dermatol; 2024 Jan; 23(1):90-98. PubMed ID: 37529982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calf-contouring surgery of gastrocnemius hypertrophy: selective neurectomy of the sural nerve.
    Kim SC; Kang MH; Ock JJ
    Aesthetic Plast Surg; 2008 Nov; 32(6):889-93. PubMed ID: 18363052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.